Literature DB >> 9533821

The beta2- and beta3-adrenoceptor-mediated relaxation induced by isoprenaline and salbutamol in guinea pig taenia caecum.

K Koike1, T Ichino, T Horinouchi, I Takayanagi.   

Abstract

To understand the receptor subtypes responsible for beta-adrenoceptor-mediated relaxation of guinea pig taenia caecum, we investigated the effects of isoprenaline and salbutamol. Isoprenaline and salbutamol caused dose-dependent relaxation of the guinea pig taenia caecum. Propranolol, bupranolol and butoxamine produced shifts of the concentration response curves for isoprenaline and salbutamol. Schild regression analyses carried out for propranolol against isoprenaline and salbutamol gave pA2 values of 8.43 and 8.88, respectively. Schild regression analyses carried out for butoxamine against isoprenaline and salbutamol gave pA2 values of 6.46 and 6.68, respectively. Schild regression analyses carried out for bupranolol against isoprenaline and salbutamol gave pA2 values of 8.60 and 8.69, respectively. However, in the presence of 3 x 10(-4) M atenolol, 10(-4) M butoxamine and 10(-6) M phentolamine to block the beta1-, beta2- and alpha-adrenoceptor effects, respectively, Schild regression analyses carried out for bupranolol against isoprenaline and salbutamol gave pA2 values of 5.77 and 5.97, respectively. These results suggest that the relaxant responses to isoprenaline and salbutamol in the guinea pig taenia caecum are mediated by both the beta2- and the beta3-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9533821     DOI: 10.1540/jsmr.33.99

Source DB:  PubMed          Journal:  J Smooth Muscle Res        ISSN: 0916-8737


  1 in total

1.  Pharmacological identification of β-adrenoceptor subtypes mediating isoprenaline-induced relaxation of guinea pig colonic longitudinal smooth muscle.

Authors:  Daisuke Chino; Tomoyo Sone; Kumi Yamazaki; Yuri Tsuruoka; Risa Yamagishi; Shunsuke Shiina; Keisuke Obara; Fumiko Yamaki; Koji Higai; Yoshio Tanaka
Journal:  J Smooth Muscle Res       Date:  2018
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.